Email this article to a friend
The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393]
-
Correspondence: Heart Protection Study Collaborative Group hps@ctsu.ox.ac.uk
BMC Medicine 2005, 3:6 doi:10.1186/1741-7015-3-6